<Summary id="CDR0000062678" LegacyPDQID="1017"><SummaryMetaData><SummaryType>Treatment</SummaryType><SummaryAudience>Patients</SummaryAudience><SummaryLanguage>English</SummaryLanguage><SummaryDescription>Pancreatic neuroendocrine tumors (islet cell tumors) treatments include surgery, hormone therapy, chemotherapy, targeted therapy, and supportive care. Learn more about the treatment of newly diagnosed and recurrent pancreatic neuroendocrine tumors in this expert-reviewed summary.</SummaryDescription><SummaryURL xref="https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment</SummaryURL><SummaryToggleURL xref="https://www.cancer.gov/types/pancreatic/hp/pnet-treatment-pdq">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment</SummaryToggleURL><SummaryEditorialBoard ref="CDR0000028327">PDQ Adult Treatment Editorial Board</SummaryEditorialBoard><MainTopics><TermRef ref="CDR0000043353">islet cell carcinoma</TermRef></MainTopics><SummaryAbstract><Para id="_247">This PDQ cancer information summary has current information about the treatment of pancreatic neuroendocrine tumors (islet cell tumors). It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para><Para id="_248">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Date Last Modified") is the date of the most recent change. The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the PDQ Adult Treatment Editorial Board.</Para></SummaryAbstract><SummaryKeyWords><SummaryKeyWord>islet cell carcinoma</SummaryKeyWord></SummaryKeyWords></SummaryMetaData><SummaryTitle>Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Patient Version</SummaryTitle><AltTitle TitleType="Browser">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment</AltTitle><AltTitle TitleType="CancerTypeHomePage">Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment</AltTitle><SummarySection id="_1"><Title>General Information About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)</Title><SummarySection id="_2"><SectMetaData><SectionType>Cancer description</SectionType><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_3">Pancreatic neuroendocrine tumors   form in hormone-making cells (islet cells) of the pancreas.</KeyPoint><Para id="_4">The <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef> is a <GlossaryTermRef href="CDR0000046386" dictionary="Cancer.gov" audience="Patient">gland</GlossaryTermRef> about 6 inches long that is shaped like a thin pear lying on its side. The wider end of the pancreas is called the head, the middle section is called the body, and the narrow end is called the tail. The pancreas lies behind the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef> and in front of the <GlossaryTermRef href="CDR0000415914" dictionary="Cancer.gov" audience="Patient">spine</GlossaryTermRef>. <MediaLink ref="CDR0000636528" type="image/jpeg" alt="Anatomy of the pancreas; drawing shows the pancreas, stomach, spleen, liver, bile ducts, gallbladder, small intestine, and colon. An inset shows the head, body, and tail of the pancreas. The bile duct and pancreatic duct are also shown." language="en" placement="image-center" id="_212"><Caption language="en">Anatomy of the pancreas. The pancreas has three areas: the head, body, and tail. It is found in the abdomen near the stomach, intestines, and other organs. </Caption></MediaLink></Para><Para id="_5">There are two kinds  of <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef> in the pancreas:</Para><ItemizedList id="_6" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000270854" dictionary="Cancer.gov" audience="Patient">Endocrine pancreas cells</GlossaryTermRef></Strong> make several kinds of <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> (chemicals that control the actions of certain cells or <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef> in the body), such as <GlossaryTermRef href="CDR0000046187" dictionary="Cancer.gov" audience="Patient">insulin</GlossaryTermRef> to control <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> sugar. They cluster together in many small groups (islets) throughout the pancreas. Endocrine pancreas cells are also called <GlossaryTermRef href="CDR0000270855" dictionary="Cancer.gov" audience="Patient">islet cells</GlossaryTermRef> or islets of Langerhans. <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">Tumors</GlossaryTermRef> that form in islet cells are called <GlossaryTermRef href="CDR0000573196" dictionary="Cancer.gov" audience="Patient">islet cell tumors</GlossaryTermRef>, pancreatic endocrine tumors, or pancreatic neuroendocrine tumors (pancreatic NETs).   </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000270856" dictionary="Cancer.gov" audience="Patient">Exocrine pancreas cells</GlossaryTermRef></Strong> make <GlossaryTermRef href="CDR0000046081" dictionary="Cancer.gov" audience="Patient">enzymes</GlossaryTermRef> that are released into the <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef> to help the body <GlossaryTermRef href="CDR0000463707" dictionary="Cancer.gov" audience="Patient">digest</GlossaryTermRef> food. Most of the pancreas is made of <GlossaryTermRef href="CDR0000046441" dictionary="Cancer.gov" audience="Patient">ducts</GlossaryTermRef> with small sacs at the end of the ducts, which are lined with <GlossaryTermRef href="CDR0000270856" dictionary="Cancer.gov" audience="Patient">exocrine cells</GlossaryTermRef>.  </ListItem></ItemizedList><Para id="_245">This summary discusses islet cell tumors of the endocrine pancreas.  See the <GlossaryTermRef href="CDR0000044271" dictionary="Cancer.gov" audience="Patient">PDQ</GlossaryTermRef> summary on <SummaryRef href="CDR0000062957" url="/types/pancreatic/patient/pancreatic-treatment-pdq">Pancreatic Cancer Treatment</SummaryRef> for information on <GlossaryTermRef href="CDR0000407747" dictionary="Cancer.gov" audience="Patient">exocrine pancreatic cancer</GlossaryTermRef>.</Para><Para id="_246"> Pancreatic neuroendocrine tumors (NETs) may be <GlossaryTermRef href="CDR0000045614" dictionary="Cancer.gov" audience="Patient">benign</GlossaryTermRef> (not <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>) or <GlossaryTermRef href="CDR0000045772" dictionary="Cancer.gov" audience="Patient">malignant</GlossaryTermRef> (cancer). When pancreatic NETs are malignant, they are called <GlossaryTermRef href="CDR0000530385" dictionary="Cancer.gov" audience="Patient">pancreatic endocrine cancer</GlossaryTermRef> or islet cell carcinoma.</Para><Para id="_218">Pancreatic NETs are much less common than pancreatic exocrine tumors and have a better <GlossaryTermRef href="CDR0000045849" dictionary="Cancer.gov" audience="Patient">prognosis</GlossaryTermRef>.</Para></SummarySection><SummarySection id="_198"><KeyPoint id="_199">Pancreatic NETs      may or may not cause signs or symptoms.</KeyPoint><Para id="_200">Pancreatic NETs may be <GlossaryTermRef href="CDR0000458094" dictionary="Cancer.gov" audience="Patient">functional</GlossaryTermRef> or <GlossaryTermRef href="CDR0000458095" dictionary="Cancer.gov" audience="Patient">nonfunctional</GlossaryTermRef>:</Para><ItemizedList id="_201" Style="bullet"><ListItem>Functional tumors make extra amounts of hormones, such as <GlossaryTermRef href="CDR0000458101" dictionary="Cancer.gov" audience="Patient">gastrin</GlossaryTermRef>, insulin, and <GlossaryTermRef href="CDR0000270860" dictionary="Cancer.gov" audience="Patient">glucagon</GlossaryTermRef>, that cause <GlossaryTermRef href="CDR0000750109" dictionary="Cancer.gov" audience="Patient">signs</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef>. </ListItem><ListItem>Nonfunctional tumors do not make extra amounts of hormones. Signs and symptoms are caused by the tumor as it spreads and grows. 

Most nonfunctional tumors are <GlossaryTermRef href="CDR0000045772" dictionary="Cancer.gov" audience="Patient">malignant</GlossaryTermRef> (cancer).</ListItem></ItemizedList><Para id="_225">Most pancreatic NETs are functional tumors.</Para></SummarySection><SummarySection id="_130"><SectMetaData><SectionType>Organ description</SectionType></SectMetaData><KeyPoint id="_131">There are different kinds of functional pancreatic NETs. </KeyPoint><Para id="_132">Pancreatic NETs make different kinds of hormones such as gastrin, insulin, and glucagon. Functional pancreatic NETs  include the following:</Para><ItemizedList id="_144" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000044239" dictionary="Cancer.gov" audience="Patient">Gastrinoma</GlossaryTermRef>:</Strong> A tumor that forms in cells that make gastrin. Gastrin is a hormone that causes the stomach to release an <GlossaryTermRef href="CDR0000642987" dictionary="Cancer.gov" audience="Patient">acid</GlossaryTermRef> that helps digest  food. Both gastrin and stomach acid are increased by   gastrinomas. When increased <GlossaryTermRef href="CDR0000657842" dictionary="Cancer.gov" audience="Patient">stomach acid</GlossaryTermRef>, stomach <GlossaryTermRef href="CDR0000269469" dictionary="Cancer.gov" audience="Patient">ulcers</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000306496" dictionary="Cancer.gov" audience="Patient">diarrhea</GlossaryTermRef>  are caused by a tumor that makes gastrin, it is called <GlossaryTermRef href="CDR0000044262" dictionary="Cancer.gov" audience="Patient">Zollinger-Ellison syndrome</GlossaryTermRef>. A gastrinoma usually  forms in the head of the pancreas and sometimes forms in the small intestine. Most gastrinomas are malignant (cancer).</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000657853" dictionary="Cancer.gov" audience="Patient">Insulinoma</GlossaryTermRef>:</Strong> A tumor that forms in cells that make insulin. Insulin is a hormone that controls the amount of <GlossaryTermRef href="CDR0000044033" dictionary="Cancer.gov" audience="Patient">glucose</GlossaryTermRef> (sugar) in the blood. It moves glucose into the cells, where it can be used by the body for energy. Insulinomas are usually slow-growing tumors that rarely spread. An insulinoma forms in the head, body, or tail of the pancreas. Insulinomas are usually benign (not cancer).</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000044280" dictionary="Cancer.gov" audience="Patient">Glucagonoma</GlossaryTermRef>:</Strong> A tumor that forms in cells that make glucagon. Glucagon is a hormone that increases the amount of glucose in the blood. It causes the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef> to break down glycogen. Too much glucagon causes <GlossaryTermRef href="CDR0000044208" dictionary="Cancer.gov" audience="Patient">hyperglycemia</GlossaryTermRef> (<GlossaryTermRef href="CDR0000597245" dictionary="Cancer.gov" audience="Patient">high blood sugar</GlossaryTermRef>). A glucagonoma usually forms in the tail of the pancreas. Most glucagonomas are malignant (cancer).</ListItem><ListItem><Strong>Other types of tumors</Strong>: There are other rare types of functional  pancreatic NETs  that make hormones, including hormones that control the balance of sugar, salt, and water in the body. These tumors include: <ItemizedList id="_195" Style="dash"><ListItem>VIPomas, which make <GlossaryTermRef href="CDR0000658067" dictionary="Cancer.gov" audience="Patient">vasoactive intestinal peptide</GlossaryTermRef>. VIPoma may also be called Verner-Morrison syndrome.</ListItem><ListItem>Somatostatinomas, which make somatostatin.</ListItem></ItemizedList>These other types of tumors are grouped together because they are treated in much the same way.</ListItem></ItemizedList></SummarySection><SummarySection id="_10"><SectMetaData><SectionType>Risk factors</SectionType></SectMetaData><KeyPoint id="_11">Having certain syndromes can increase the risk of pancreatic NETs. </KeyPoint><Para id="_128">Anything that increases your risk of getting a disease is called 
         a <GlossaryTermRef href="CDR0000045873" dictionary="Cancer.gov" audience="Patient">risk factor</GlossaryTermRef>.  Having a risk factor does not mean that you will 
         get cancer; not having risk factors doesn't mean that you will 
         not get cancer. Talk with your doctor if you think you may be at risk.  </Para><Para id="_149"><GlossaryTermRef href="CDR0000270861" dictionary="Cancer.gov" audience="Patient">Multiple endocrine neoplasia type 1 (MEN1) syndrome</GlossaryTermRef> is a risk factor for pancreatic NETs.</Para></SummarySection><SummarySection id="_13"><SectMetaData><SectionType>Symptoms</SectionType></SectMetaData><KeyPoint id="_14">Different types of pancreatic NETs  have different signs and symptoms. 
     </KeyPoint><Para id="_15">Signs or symptoms can be caused by the growth of the tumor and/or by hormones the tumor makes or by other <GlossaryTermRef href="CDR0000651193" dictionary="Cancer.gov" audience="Patient">conditions</GlossaryTermRef>. Some tumors may not cause signs or symptoms. Check with your doctor if you have any of these problems. </Para><Para id="_133"><Strong>Signs and symptoms of a non-functional pancreatic NET</Strong> 

</Para><Para id="_134">A non-functional pancreatic NET may grow for a long time without causing signs or symptoms. It may grow large or spread to other parts of the body before it causes signs or symptoms, such as:    </Para><ItemizedList id="_148" Style="bullet"><ListItem>Diarrhea.</ListItem><ListItem>Indigestion.</ListItem><ListItem>A lump in the <GlossaryTermRef href="CDR0000045070" dictionary="Cancer.gov" audience="Patient">abdomen</GlossaryTermRef>.</ListItem><ListItem>Pain in the abdomen or back.</ListItem><ListItem>Yellowing of the skin and whites of the eyes.</ListItem></ItemizedList><Para id="_136"><Strong>Signs and symptoms of a functional pancreatic NET</Strong> 

</Para><Para id="_137">The signs and symptoms of a functional pancreatic NET depend on the type of hormone being made.

</Para><Para id="_138"><Strong>Too much gastrin may cause:</Strong></Para><ItemizedList id="_139" Style="bullet"><ListItem>Stomach ulcers that keep coming back.</ListItem><ListItem>Pain in the abdomen, which may spread to the back. The pain may come and go and it may go away after taking an antacid.</ListItem><ListItem>The flow of stomach contents back into the <GlossaryTermRef href="CDR0000046408" dictionary="Cancer.gov" audience="Patient">esophagus</GlossaryTermRef> (<GlossaryTermRef href="CDR0000257517" dictionary="Cancer.gov" audience="Patient">gastroesophageal reflux</GlossaryTermRef>).</ListItem><ListItem>Diarrhea.</ListItem></ItemizedList><Para id="_140"><Strong>Too much insulin may cause:</Strong></Para><ItemizedList id="_141" Style="bullet"><ListItem>Low <GlossaryTermRef href="CDR0000658770" dictionary="Cancer.gov" audience="Patient">blood sugar</GlossaryTermRef>. This can cause blurred vision, headache, and feeling lightheaded, tired, weak, shaky, nervous, irritable, sweaty, confused, or hungry.</ListItem><ListItem>Fast heartbeat.</ListItem></ItemizedList><Para id="_142"><Strong>Too much glucagon may cause:</Strong></Para><ItemizedList id="_143" Style="bullet"><ListItem>Skin rash on the face, stomach, or legs.</ListItem><ListItem>High blood sugar. This can cause headaches, frequent <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urination</GlossaryTermRef>, dry skin and mouth, or feeling hungry, thirsty, tired, or weak. </ListItem><ListItem><GlossaryTermRef href="CDR0000476017" dictionary="Cancer.gov" audience="Patient">Blood clots</GlossaryTermRef>. Blood clots in the <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef> can cause shortness of breath, cough, or pain in the chest. Blood clots in the arm or leg can cause pain, swelling, warmth, or redness of the arm or leg.</ListItem><ListItem>Diarrhea.</ListItem><ListItem>Weight loss for no known reason.</ListItem><ListItem>Sore tongue or sores at the corners of the mouth.</ListItem></ItemizedList><Para id="_145"><Strong>Too much vasoactive intestinal peptide (VIP) may cause:</Strong></Para><ItemizedList id="_146" Style="bullet"><ListItem>Very large amounts of watery diarrhea.</ListItem><ListItem><GlossaryTermRef href="CDR0000044659" dictionary="Cancer.gov" audience="Patient">Dehydration</GlossaryTermRef>. This can cause feeling thirsty, making less <GlossaryTermRef href="CDR0000046642" dictionary="Cancer.gov" audience="Patient">urine</GlossaryTermRef>, dry skin and mouth, headaches, dizziness, or feeling tired.</ListItem><ListItem>Low <GlossaryTermRef href="CDR0000044344" dictionary="Cancer.gov" audience="Patient">potassium</GlossaryTermRef> level in the blood. This can cause muscle weakness, aching, or cramps, numbness and tingling, frequent urination, fast heartbeat, and feeling confused or thirsty.</ListItem><ListItem>Cramps or pain in the abdomen.</ListItem><ListItem>Weight loss for no known reason.</ListItem></ItemizedList><Para id="_183"><Strong>Too much somatostatin may cause:</Strong></Para><ItemizedList id="_184" Style="bullet"><ListItem>High blood sugar. This can cause headaches, frequent urination, dry skin and mouth, or feeling hungry, thirsty, tired, or weak. </ListItem><ListItem>Diarrhea.</ListItem><ListItem>Steatorrhea (very foul-smelling <GlossaryTermRef href="CDR0000046605" dictionary="Cancer.gov" audience="Patient">stool</GlossaryTermRef> that floats).</ListItem><ListItem><GlossaryTermRef href="CDR0000322135" dictionary="Cancer.gov" audience="Patient">Gallstones</GlossaryTermRef>.</ListItem><ListItem>Yellowing of the skin and whites of the eyes.</ListItem><ListItem>Weight loss for no known reason.</ListItem></ItemizedList><Para id="_253">A pancreatic NET may also make too much <GlossaryTermRef href="CDR0000476632" dictionary="Cancer.gov" audience="Patient">adrenocorticotropic hormone</GlossaryTermRef> (ACTH) and cause <GlossaryTermRef href="CDR0000626500" dictionary="Cancer.gov" audience="Patient">Cushing syndrome</GlossaryTermRef>. Signs and symptoms of Cushing syndrome include the following:</Para><ItemizedList id="_254" Style="bullet"><ListItem>Headache.</ListItem><ListItem>Some loss of vision.</ListItem><ListItem>Weight gain in the face, neck, and <GlossaryTermRef href="CDR0000796908" dictionary="Cancer.gov" audience="Patient">trunk</GlossaryTermRef> of the body, and thin arms and legs.  </ListItem><ListItem>A lump of fat on the back of the neck.</ListItem><ListItem>Thin skin that may have purple or pink stretch marks on the chest or abdomen.</ListItem><ListItem>Easy bruising.</ListItem><ListItem>Growth of fine hair on the face, upper back, or arms.</ListItem><ListItem>Bones that break easily.</ListItem><ListItem>Sores or cuts that heal slowly.</ListItem><ListItem><GlossaryTermRef href="CDR0000430405" dictionary="Cancer.gov" audience="Patient">Anxiety</GlossaryTermRef>, irritability, and <GlossaryTermRef href="CDR0000430479" dictionary="Cancer.gov" audience="Patient">depression</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_255">The treatment of pancreatic NETs that make too much ACTH and Cushing syndrome are not discussed in this summary.</Para></SummarySection><SummarySection id="_17"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_18">Lab tests and imaging tests are used to diagnose pancreatic NETs. </KeyPoint><Para id="_85">The following tests and procedures may be used:</Para><ItemizedList id="_162" Style="bullet"><ListItem><Strong><GlossaryTermRef href="CDR0000270871" dictionary="Cancer.gov" audience="Patient">Physical exam</GlossaryTermRef> and <GlossaryTermRef href="CDR0000798522" dictionary="Cancer.gov" audience="Patient">health history</GlossaryTermRef></Strong>: An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patient’s health habits and past illnesses and treatments will also be taken.
</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000304685" dictionary="Cancer.gov" audience="Patient">Blood chemistry studies</GlossaryTermRef></Strong>: A procedure in which a blood sample is checked to measure the amounts of certain substances, such as glucose (sugar), released into the blood by organs and <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissues</GlossaryTermRef> in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000721302" dictionary="Cancer.gov" audience="Patient">Chromogranin A</GlossaryTermRef> test</Strong>: A test in which a blood sample is checked to measure the amount of chromogranin A in the blood. A higher than normal amount of chromogranin A and normal amounts of hormones such as gastrin, insulin, and glucagon can be a sign of a non-functional pancreatic NET. </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046684" dictionary="Cancer.gov" audience="Patient">Abdominal</GlossaryTermRef> <GlossaryTermRef href="CDR0000046033" dictionary="Cancer.gov" audience="Patient">CT scan</GlossaryTermRef> (CAT scan)</Strong>: A procedure that makes a series of detailed pictures of the abdomen, taken from different angles.  The pictures are made by a computer linked to an <GlossaryTermRef href="CDR0000045944" dictionary="Cancer.gov" audience="Patient">x-ray</GlossaryTermRef> machine. A <GlossaryTermRef href="CDR0000409764" dictionary="Cancer.gov" audience="Patient">dye</GlossaryTermRef> may be <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> or swallowed to help the organs or tissues show up more clearly.  This procedure is also called computed tomography, computerized tomography, or computerized axial tomography.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045788" dictionary="Cancer.gov" audience="Patient">MRI</GlossaryTermRef> (magnetic resonance imaging)</Strong>: A procedure that uses a magnet, <GlossaryTermRef href="CDR0000651209" dictionary="Cancer.gov" audience="Patient">radio waves</GlossaryTermRef>, and a computer to make a series of detailed pictures of areas inside the body. This procedure is also called nuclear magnetic resonance imaging (NMRI).</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000390250" dictionary="Cancer.gov" audience="Patient">Somatostatin receptor scintigraphy</GlossaryTermRef></Strong>:

  A type of <GlossaryTermRef href="CDR0000046552" dictionary="Cancer.gov" audience="Patient">radionuclide scan</GlossaryTermRef> that may be used to find small pancreatic NETs.     A small amount of <GlossaryTermRef href="CDR0000046550" dictionary="Cancer.gov" audience="Patient">radioactive</GlossaryTermRef> <GlossaryTermRef href="CDR0000045141" dictionary="Cancer.gov" audience="Patient">octreotide</GlossaryTermRef> (a hormone that attaches to  tumors) is injected into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.   
</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046602" dictionary="Cancer.gov" audience="Patient">Endoscopic ultrasound</GlossaryTermRef> (EUS)</Strong>: A procedure in which an <GlossaryTermRef href="CDR0000046428" dictionary="Cancer.gov" audience="Patient">endoscope</GlossaryTermRef>  is inserted into the body, usually through the mouth or <GlossaryTermRef href="CDR0000046555" dictionary="Cancer.gov" audience="Patient">rectum</GlossaryTermRef>.  An endoscope is a thin, tube-like instrument with a light and a <GlossaryTermRef href="CDR0000572035" dictionary="Cancer.gov" audience="Patient">lens</GlossaryTermRef> for viewing. A probe at the end of the endoscope is used to bounce high-energy sound waves (<GlossaryTermRef href="CDR0000046157" dictionary="Cancer.gov" audience="Patient">ultrasound</GlossaryTermRef>) off internal tissues or organs and make echoes.  The echoes form a picture of body tissues called a <GlossaryTermRef href="CDR0000046587" dictionary="Cancer.gov" audience="Patient">sonogram</GlossaryTermRef>.  This procedure is also called endosonography.

</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046429" dictionary="Cancer.gov" audience="Patient">Endoscopic retrograde cholangiopancreatography</GlossaryTermRef> (ERCP)</Strong>:  A procedure used to x-ray the ducts (tubes) that carry <GlossaryTermRef href="CDR0000046508" dictionary="Cancer.gov" audience="Patient">bile</GlossaryTermRef> from the liver to the <GlossaryTermRef href="CDR0000046395" dictionary="Cancer.gov" audience="Patient">gallbladder</GlossaryTermRef> and from the gallbladder to the small intestine.  Sometimes pancreatic cancer causes these ducts to narrow and block or slow the flow of bile, causing <GlossaryTermRef href="CDR0000046328" dictionary="Cancer.gov" audience="Patient">jaundice</GlossaryTermRef>.  An endoscope  is passed through the mouth, esophagus, and stomach into the first part of the small intestine.  An endoscope is a thin, tube-like instrument with a light and a lens for viewing. A <GlossaryTermRef href="CDR0000045637" dictionary="Cancer.gov" audience="Patient">catheter</GlossaryTermRef> (a smaller tube) is then inserted through the endoscope into the pancreatic ducts.  A dye is injected through the catheter into the ducts and an x-ray is taken.  If the ducts are blocked by a tumor, a fine tube may be inserted into the duct to unblock it.  This tube (or <GlossaryTermRef href="CDR0000044903" dictionary="Cancer.gov" audience="Patient">stent</GlossaryTermRef>) may be left in place to keep the duct open.  Tissue samples may also be taken and checked under a <GlossaryTermRef href="CDR0000638184" dictionary="Cancer.gov" audience="Patient">microscope</GlossaryTermRef> for signs of cancer.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046530" dictionary="Cancer.gov" audience="Patient">Angiogram</GlossaryTermRef></Strong>: A procedure to look at <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessels</GlossaryTermRef> and the flow of blood.  A <GlossaryTermRef href="CDR0000409764" dictionary="Cancer.gov" audience="Patient">contrast dye</GlossaryTermRef> is injected into the blood vessel.  As the contrast dye moves through the blood vessel, x-rays are taken to see if there are any blockages.

</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045747" dictionary="Cancer.gov" audience="Patient">Laparotomy</GlossaryTermRef></Strong>: A <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgical</GlossaryTermRef> procedure in which an <GlossaryTermRef href="CDR0000046353" dictionary="Cancer.gov" audience="Patient">incision</GlossaryTermRef> (cut) is made in the wall of the abdomen to check the inside of the abdomen for signs of disease. The size of the incision depends on the reason the laparotomy is being done. Sometimes organs are removed or tissue samples are taken and checked under a <GlossaryTermRef href="CDR0000638184" dictionary="Cancer.gov" audience="Patient">microscope</GlossaryTermRef> for signs of disease.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000657859" dictionary="Cancer.gov" audience="Patient">Intraoperative ultrasound</GlossaryTermRef></Strong>: A procedure that uses high-energy sound waves (ultrasound) to create images of internal organs or  tissues during surgery. A transducer placed directly on the organ or tissue is used to make the  sound waves, which create echoes. The transducer receives the echoes and sends them to a computer, which uses the echoes to make pictures called sonograms.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045164" dictionary="Cancer.gov" audience="Patient">Biopsy</GlossaryTermRef></Strong>: The removal of cells or tissues so they can be viewed under a microscope by a <GlossaryTermRef href="CDR0000046244" dictionary="Cancer.gov" audience="Patient">pathologist</GlossaryTermRef> to check for signs of cancer. There are several ways to do a biopsy for pancreatic NETs. Cells may be removed using a fine or wide needle inserted into the pancreas during an x-ray or ultrasound. Tissue may also be removed during a <GlossaryTermRef href="CDR0000045556" dictionary="Cancer.gov" audience="Patient">laparoscopy</GlossaryTermRef> (a surgical incision made in the wall of the abdomen).</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046499" dictionary="Cancer.gov" audience="Patient">Bone scan</GlossaryTermRef></Strong>: A procedure to check if there are rapidly dividing cells, such as cancer cells, in the bone.  A very small amount of radioactive material is injected into a vein and travels through the bloodstream.  The radioactive material collects in  bones with cancer and is detected by a <GlossaryTermRef href="CDR0000386220" dictionary="Cancer.gov" audience="Patient">scanner</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection><SummarySection id="_210"><KeyPoint id="_211">Other kinds of lab tests are used to check for the specific type of pancreatic NETs.</KeyPoint><Para id="_190">The following tests and procedures may be used:</Para><Para id="_170"><Strong>Gastrinoma</Strong></Para><ItemizedList id="_164" Style="bullet"><ListItem><Strong>Fasting <GlossaryTermRef href="CDR0000044088" dictionary="Cancer.gov" audience="Patient">serum</GlossaryTermRef> gastrin test</Strong>: A test in which a blood sample is checked to measure the amount of gastrin in the blood. This test is done after the patient has had nothing to eat or drink for at least 8 hours.  Conditions other than gastrinoma can cause an increase in the  amount of gastrin in the blood.</ListItem><ListItem><Strong>Basal acid output test</Strong>: A test to measure the amount of acid made by the stomach. The test is done after the patient has had nothing to eat or drink for at least 8 hours. A tube is inserted through the nose or <GlossaryTermRef href="CDR0000439429" dictionary="Cancer.gov" audience="Patient">throat</GlossaryTermRef>, into the stomach. The stomach contents are removed and four samples of gastric acid are removed through the tube. These samples are used to find out the amount of gastric acid  made during the test and the <GlossaryTermRef href="CDR0000747897" dictionary="Cancer.gov" audience="Patient">pH</GlossaryTermRef> level of the <GlossaryTermRef href="CDR0000046770" dictionary="Cancer.gov" audience="Patient">gastric</GlossaryTermRef> <GlossaryTermRef href="CDR0000643082" dictionary="Cancer.gov" audience="Patient">secretions</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000658058" dictionary="Cancer.gov" audience="Patient">Secretin stimulation test</GlossaryTermRef></Strong>: If the basal acid output test result is not normal, a secretin stimulation test may be done. The tube is moved into the small intestine and samples are taken from the small intestine after  a <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drug</GlossaryTermRef> called <GlossaryTermRef href="CDR0000658055" dictionary="Cancer.gov" audience="Patient">secretin</GlossaryTermRef> is injected. Secretin causes the small intestine to make acid. When there is a gastrinoma, the secretin causes an increase in how much gastric acid is made and the level of  gastrin in the blood.</ListItem><ListItem><Strong>Somatostatin receptor scintigraphy</Strong>:

  A type of radionuclide scan that may be used to find small pancreatic NETs. A small amount of radioactive octreotide (a hormone that attaches to  tumors) is injected into a vein and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.</ListItem></ItemizedList><Para id="_171"><Strong>Insulinoma</Strong></Para><ItemizedList id="_165" Style="bullet"><ListItem><Strong>Fasting serum glucose and insulin test</Strong>: A test in which a blood sample is checked to measure the amounts of glucose (sugar) and insulin in the blood. The test is done after the patient has had nothing to eat or drink for at least 24 hours. </ListItem></ItemizedList><Para id="_172"><Strong>Glucagonoma</Strong></Para><ItemizedList id="_166" Style="bullet"><ListItem><Strong>Fasting serum glucagon test</Strong>: A test in which a blood sample is checked to measure the amount of glucagon in the blood. The test is done after the patient has had nothing to eat or drink for at least 8 hours.   </ListItem></ItemizedList><Para id="_173"><Strong>Other tumor types</Strong></Para><ItemizedList id="_167" Style="bullet"><ListItem>VIPoma<ItemizedList id="_180" Style="dash"><ListItem><Strong>Serum <GlossaryTermRef href="CDR0000658069" dictionary="Cancer.gov" audience="Patient">VIP</GlossaryTermRef> (vasoactive intestinal peptide) test</Strong>: A test in which a blood sample is checked to measure the amount of VIP. </ListItem><ListItem><Strong>Blood chemistry studies</Strong>: A procedure in which a blood sample is checked to measure the amounts of certain substances released into the blood by organs and tissues in the body. An unusual (higher or lower than normal) amount of a substance can be a sign of disease. In VIPoma, there is a lower than normal amount of potassium.</ListItem><ListItem><Strong>Stool <GlossaryTermRef href="CDR0000390238" dictionary="Cancer.gov" audience="Patient">analysis</GlossaryTermRef></Strong>: A stool sample is checked for a higher than normal <GlossaryTermRef href="CDR0000044731" dictionary="Cancer.gov" audience="Patient">sodium</GlossaryTermRef> (salt) and potassium levels.</ListItem></ItemizedList></ListItem><ListItem>Somatostatinoma<ItemizedList id="_181" Style="dash"><ListItem><Strong>Fasting serum somatostatin test</Strong>: A test in which a blood sample is checked to measure the amount of somatostatin in the blood. The test is done after the patient has had nothing to eat or drink for at least 8 hours.</ListItem><ListItem><Strong>Somatostatin receptor scintigraphy</Strong>:

  A type of radionuclide scan that may be used to find small pancreatic NETs. A small amount of radioactive octreotide (a hormone that attaches to  tumors) is injected into a vein and travels through the blood. The radioactive octreotide attaches to the tumor and a special camera that detects radioactivity is used to show where the tumors are in the body. This procedure is also called octreotide scan and SRS.   
</ListItem></ItemizedList></ListItem></ItemizedList></SummarySection><SummarySection id="_21"><SectMetaData><SectionType>Prognostic factors</SectionType></SectMetaData><KeyPoint id="_22">Certain factors affect prognosis (chance of recovery) and treatment options.</KeyPoint><Para id="_104">Pancreatic NETs can often be <GlossaryTermRef href="CDR0000318813" dictionary="Cancer.gov" audience="Patient">cured</GlossaryTermRef>. The <GlossaryTermRef href="CDR0000045849" dictionary="Cancer.gov" audience="Patient">prognosis</GlossaryTermRef> and treatment options depend on the following:</Para><ItemizedList id="_105" Style="bullet">
    <ListItem>The type of cancer cell.</ListItem><ListItem>Where the tumor is found in the pancreas. </ListItem><ListItem>Whether the tumor has spread to more than one place in the pancreas or to other parts of the body.</ListItem><ListItem>Whether the patient has MEN1 syndrome.</ListItem><ListItem>The patient's age and  general health.</ListItem>
    
    <ListItem>Whether the cancer has just been <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnosed</GlossaryTermRef> or has <GlossaryTermRef href="CDR0000046556" dictionary="Cancer.gov" audience="Patient">recurred</GlossaryTermRef> (come back).</ListItem>
   </ItemizedList></SummarySection></SummarySection><SummarySection id="_24"><Title>Stages of Pancreatic Neuroendocrine Tumors     </Title><SummarySection id="_108"><SectMetaData><SectionType>Diagnostic tests</SectionType></SectMetaData><KeyPoint id="_191">The plan for cancer treatment depends on where the NET is found in the pancreas and whether it has spread.

</KeyPoint><Para id="_223">The process used to find out if <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> has spread within the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef> or to other parts of the body is called <GlossaryTermRef href="CDR0000046597" dictionary="Cancer.gov" audience="Patient">staging</GlossaryTermRef>. The results of the tests and procedures used to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> <GlossaryTermRef href="CDR0000753531" dictionary="Cancer.gov" audience="Patient">pancreatic neuroendocrine tumors</GlossaryTermRef> (NETs) are also used to find out whether the cancer has spread. See the <SummaryRef href="CDR0000062678#_17" url="/types/pancreatic/patient/pnet-treatment-pdq">General Information</SummaryRef> section for a description of these tests and procedures.  </Para><Para id="_224">Although there is a standard <GlossaryTermRef href="CDR0000689095" dictionary="Cancer.gov" audience="Patient">staging system</GlossaryTermRef> for pancreatic NETs, it  is not used to plan treatment. Treatment of pancreatic NETs is based on the following:

</Para><ItemizedList id="_193" Style="bullet"><ListItem>Whether the cancer is found in one place in the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef>.</ListItem><ListItem>Whether the cancer is found in several places in the pancreas.</ListItem><ListItem>Whether the cancer has spread to <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> near the pancreas or to other parts of the body such as the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, <GlossaryTermRef href="CDR0000270740" dictionary="Cancer.gov" audience="Patient">lung</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045829" dictionary="Cancer.gov" audience="Patient">peritoneum</GlossaryTermRef>, or bone.</ListItem></ItemizedList></SummarySection><SummarySection id="_114"><KeyPoint id="_115">There are three ways that cancer spreads in the body.</KeyPoint><Para id="_114_md_69">Cancer can spread through <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef>, the <GlossaryTermRef href="CDR0000045764" dictionary="Cancer.gov" audience="Patient">lymph system</GlossaryTermRef>, and the <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef>:</Para><ItemizedList id="_114_md_70" Style="bullet"><ListItem>Tissue. The cancer spreads from where it began by growing into nearby areas.
</ListItem><ListItem>Lymph system. The cancer spreads from where it began by getting into the lymph system. The cancer travels through the <GlossaryTermRef href="CDR0000269462" dictionary="Cancer.gov" audience="Patient">lymph vessels</GlossaryTermRef> to other parts of the body.
</ListItem><ListItem>Blood. The cancer spreads from where it began by getting into the blood. The cancer travels through the <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessels</GlossaryTermRef> to other parts of the body.
</ListItem></ItemizedList></SummarySection><SummarySection id="_242"><KeyPoint id="_243">Cancer may spread from where it began to other parts of the body.</KeyPoint><Para id="_242_md_66">When cancer spreads to another part of the body, it is called <GlossaryTermRef href="CDR0000046710" dictionary="Cancer.gov" audience="Patient">metastasis</GlossaryTermRef>. Cancer cells break away from where they began (the <GlossaryTermRef href="CDR0000045847" dictionary="Cancer.gov" audience="Patient">primary tumor</GlossaryTermRef>) and travel through the lymph system or blood.</Para><ItemizedList id="_242_md_67" Style="bullet"><ListItem>Lymph system. The cancer gets into the lymph system, travels through the lymph vessels, and forms a <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> (<GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef> tumor) in another part of the body.</ListItem><ListItem>Blood. The cancer gets into the blood, travels through the blood vessels, and forms a tumor (metastatic tumor) in another part of the body.</ListItem></ItemizedList><Para id="_244">The metastatic tumor is the same type of tumor as the primary tumor. For example, if   a pancreatic neuroendocrine tumor spreads to the liver, the tumor cells in the liver are actually neuroendocrine tumor cells. The disease is metastatic pancreatic neuroendocrine tumor, not liver cancer.</Para><EmbeddedVideo id="_249" ref="CDR0000787719" hosting="youtube" unique_id="fQwar_-QdiQ" language="en" audience="Patients" template="Video75NoTitle"><VideoTitle>metastasis: how cancer spreads</VideoTitle><Caption language="en">Many cancer deaths are caused when cancer moves from the original tumor and spreads to other tissues and organs. This is called metastatic cancer. This animation shows how cancer cells travel from the place in the body where they first formed to other parts of the body.</Caption></EmbeddedVideo></SummarySection><SummarySection id="_269"><KeyPoint id="_270">Pancreatic NETs can recur (come back) after they have been treated.</KeyPoint><Para id="_271">The tumors may come back in the pancreas or in other parts of the body.</Para></SummarySection></SummarySection><SummarySection id="_42"><Title>Treatment Option Overview</Title><SummarySection id="_43"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_44">There are different types of treatment for  patients with pancreatic NETs. </KeyPoint><Para id="_116">
     Different types of 
         treatments are available for patients with <GlossaryTermRef href="CDR0000753531" dictionary="Cancer.gov" audience="Patient">pancreatic neuroendocrine tumors</GlossaryTermRef> (NETs). Some 
         treatments are <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard</GlossaryTermRef> (the currently used treatment), and 
         some are being tested in <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trials</GlossaryTermRef>.  A treatment clinical 
         trial is a <GlossaryTermRef href="CDR0000651211" dictionary="Cancer.gov" audience="Patient">research study</GlossaryTermRef> meant to help improve current 
         treatments or obtain information on new treatments for patients 
         with <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>. When clinical trials show that a new treatment is 
         better than the  standard treatment, the new treatment may 
         become the standard treatment. Patients may want to think about 
         taking part in a clinical trial. Some clinical trials are open 
         only to patients who have not started treatment.</Para></SummarySection><SummarySection id="_47"><SectMetaData><SectionType>Standard treatment</SectionType></SectMetaData><KeyPoint id="_48">The following types of treatment are used:</KeyPoint><SummarySection id="_49"><KeyPoint id="_50">Surgery</KeyPoint><Para id="_51">     An operation may be done to remove the <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef>. One of the following types of <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgery</GlossaryTermRef> may be used:</Para><ItemizedList id="_83" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000335065" dictionary="Cancer.gov" audience="Patient">Enucleation</GlossaryTermRef>: Surgery to remove the tumor only. This may be done when cancer occurs in one place in the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef>.</ListItem> <ListItem><GlossaryTermRef href="CDR0000717157" dictionary="Cancer.gov" audience="Patient">Pancreatoduodenectomy</GlossaryTermRef>: A surgical procedure in which the head of the pancreas, the <GlossaryTermRef href="CDR0000046395" dictionary="Cancer.gov" audience="Patient">gallbladder</GlossaryTermRef>, nearby <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> and part of the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046738" dictionary="Cancer.gov" audience="Patient">bile duct</GlossaryTermRef> are removed.  Enough of the pancreas is left to make <GlossaryTermRef href="CDR0000463707" dictionary="Cancer.gov" audience="Patient">digestive</GlossaryTermRef> juices and <GlossaryTermRef href="CDR0000046187" dictionary="Cancer.gov" audience="Patient">insulin</GlossaryTermRef>. The <GlossaryTermRef href="CDR0000257523" dictionary="Cancer.gov" audience="Patient">organs</GlossaryTermRef> removed during this procedure depend on the patient's <GlossaryTermRef href="CDR0000651193" dictionary="Cancer.gov" audience="Patient">condition</GlossaryTermRef>. This is also called the <GlossaryTermRef href="CDR0000046653" dictionary="Cancer.gov" audience="Patient">Whipple procedure</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044519" dictionary="Cancer.gov" audience="Patient">Distal pancreatectomy</GlossaryTermRef>: Surgery to remove the body and  tail of the
				pancreas. The <GlossaryTermRef href="CDR0000046593" dictionary="Cancer.gov" audience="Patient">spleen</GlossaryTermRef> may also be removed if cancer has spread to the spleen.</ListItem><ListItem>Total <GlossaryTermRef href="CDR0000046397" dictionary="Cancer.gov" audience="Patient">gastrectomy</GlossaryTermRef>: Surgery to remove the whole stomach.</ListItem><ListItem><GlossaryTermRef href="CDR0000658043" dictionary="Cancer.gov" audience="Patient">Parietal cell vagotomy</GlossaryTermRef>: Surgery to cut the <GlossaryTermRef href="CDR0000373935" dictionary="Cancer.gov" audience="Patient">nerve</GlossaryTermRef> that causes stomach <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef> to make <GlossaryTermRef href="CDR0000657842" dictionary="Cancer.gov" audience="Patient">acid</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">Liver</GlossaryTermRef> <GlossaryTermRef href="CDR0000046565" dictionary="Cancer.gov" audience="Patient">resection</GlossaryTermRef>: Surgery to remove part or all of the liver.</ListItem><ListItem><GlossaryTermRef href="CDR0000044865" dictionary="Cancer.gov" audience="Patient">Radiofrequency ablation</GlossaryTermRef>: The use of a special probe with tiny electrodes that kill cancer cells. Sometimes the probe is inserted directly through the skin and only <GlossaryTermRef href="CDR0000044523" dictionary="Cancer.gov" audience="Patient">local anesthesia</GlossaryTermRef> is needed. In other cases, the probe is inserted through an <GlossaryTermRef href="CDR0000046353" dictionary="Cancer.gov" audience="Patient">incision</GlossaryTermRef> in the <GlossaryTermRef href="CDR0000045070" dictionary="Cancer.gov" audience="Patient">abdomen</GlossaryTermRef>. This is done in the hospital with <GlossaryTermRef href="CDR0000044561" dictionary="Cancer.gov" audience="Patient">general anesthesia</GlossaryTermRef>. 
</ListItem><ListItem><GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">Cryosurgical</GlossaryTermRef> <GlossaryTermRef href="CDR0000335061" dictionary="Cancer.gov" audience="Patient">ablation</GlossaryTermRef>: A procedure in which <GlossaryTermRef href="CDR0000046683" dictionary="Cancer.gov" audience="Patient">tissue</GlossaryTermRef> is frozen to destroy <GlossaryTermRef href="CDR0000044636" dictionary="Cancer.gov" audience="Patient">abnormal</GlossaryTermRef> cells. This is usually done with a special instrument that contains liquid nitrogen or liquid <GlossaryTermRef href="CDR0000538147" dictionary="Cancer.gov" audience="Patient">carbon dioxide</GlossaryTermRef>. The instrument may be used during surgery or <GlossaryTermRef href="CDR0000045556" dictionary="Cancer.gov" audience="Patient">laparoscopy</GlossaryTermRef> or inserted through the skin. This procedure is also called <GlossaryTermRef href="CDR0000518326" dictionary="Cancer.gov" audience="Patient">cryoablation</GlossaryTermRef>. </ListItem></ItemizedList></SummarySection><SummarySection id="_56"><KeyPoint id="_57">Chemotherapy</KeyPoint><Para id="_96"><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef> is a cancer treatment that uses <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drugs</GlossaryTermRef> to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injected</GlossaryTermRef> into a <GlossaryTermRef href="CDR0000476471" dictionary="Cancer.gov" audience="Patient">vein</GlossaryTermRef> or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (<GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>).  When chemotherapy is placed directly into the <GlossaryTermRef href="CDR0000046483" dictionary="Cancer.gov" audience="Patient">cerebrospinal fluid</GlossaryTermRef>, an organ, or a body <GlossaryTermRef href="CDR0000463703" dictionary="Cancer.gov" audience="Patient">cavity</GlossaryTermRef> such as the abdomen, the drugs mainly affect cancer cells in those areas (<GlossaryTermRef href="CDR0000046559" dictionary="Cancer.gov" audience="Patient">regional chemotherapy</GlossaryTermRef>). <GlossaryTermRef href="CDR0000045650" dictionary="Cancer.gov" audience="Patient">Combination chemotherapy</GlossaryTermRef> is the use of more than one  anticancer drug. The way the chemotherapy is given depends on the type of the cancer being treated.</Para></SummarySection><SummarySection id="_86"><KeyPoint id="_60">Hormone therapy</KeyPoint><Para id="_97"><GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">Hormone therapy</GlossaryTermRef> is a cancer treatment that removes <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> or blocks their action and stops cancer cells from growing. Hormones are substances made by <GlossaryTermRef href="CDR0000046386" dictionary="Cancer.gov" audience="Patient">glands</GlossaryTermRef> in the body and circulated in the bloodstream. Some hormones can cause certain cancers to grow. If tests show that the cancer cells have places where hormones can attach (<GlossaryTermRef href="CDR0000044958" dictionary="Cancer.gov" audience="Patient">receptors</GlossaryTermRef>), drugs, surgery, or <GlossaryTermRef href="CDR0000044971" dictionary="Cancer.gov" audience="Patient">radiation therapy</GlossaryTermRef> is used to reduce the production of hormones or block them from working.</Para></SummarySection><SummarySection id="_87"><KeyPoint id="_88">Hepatic arterial occlusion or chemoembolization</KeyPoint><Para id="_89">
     <GlossaryTermRef href="CDR0000458102" dictionary="Cancer.gov" audience="Patient">Hepatic arterial occlusion</GlossaryTermRef> uses drugs, small particles, or other agents to block or reduce the flow of <GlossaryTermRef href="CDR0000270735" dictionary="Cancer.gov" audience="Patient">blood</GlossaryTermRef> to the liver through the <GlossaryTermRef href="CDR0000044563" dictionary="Cancer.gov" audience="Patient">hepatic artery</GlossaryTermRef> (the major <GlossaryTermRef href="CDR0000045020" dictionary="Cancer.gov" audience="Patient">blood vessel</GlossaryTermRef> that carries blood to the liver). This is done to kill cancer cells growing in the liver. 
The tumor is prevented from getting the <GlossaryTermRef href="CDR0000538149" dictionary="Cancer.gov" audience="Patient">oxygen</GlossaryTermRef> and <GlossaryTermRef href="CDR0000044697" dictionary="Cancer.gov" audience="Patient">nutrients</GlossaryTermRef> it needs to grow. The liver continues to receive blood from the <GlossaryTermRef href="CDR0000044564" dictionary="Cancer.gov" audience="Patient">hepatic portal vein</GlossaryTermRef>, which carries blood from the stomach and <GlossaryTermRef href="CDR0000046335" dictionary="Cancer.gov" audience="Patient">intestine</GlossaryTermRef>.</Para><Para id="_186">Chemotherapy delivered during hepatic arterial occlusion is called <GlossaryTermRef href="CDR0000046708" dictionary="Cancer.gov" audience="Patient">chemoembolization</GlossaryTermRef>. The anticancer drug is injected into the hepatic artery  through a <GlossaryTermRef href="CDR0000045637" dictionary="Cancer.gov" audience="Patient">catheter</GlossaryTermRef> (thin tube). The drug is mixed with the substance that blocks the <GlossaryTermRef href="CDR0000440100" dictionary="Cancer.gov" audience="Patient">artery</GlossaryTermRef> and cuts off blood flow to the tumor. Most of the anticancer drug is trapped near the tumor and only a small amount of the drug reaches other parts of the body.</Para><Para id="_179">The blockage may be temporary or permanent, depending on the substance used to block the artery. </Para></SummarySection><SummarySection id="_237"><KeyPoint id="_238">Targeted therapy</KeyPoint><Para id="_239"><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef> is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. Targeted therapies usually cause less harm to normal cells than chemotherapy or radiation therapy do. Certain types of targeted therapies are being studied in the treatment of pancreatic NETs.</Para></SummarySection><SummarySection id="_203"><KeyPoint id="_204">Supportive care</KeyPoint><Para id="_205"><GlossaryTermRef href="CDR0000046609" dictionary="Cancer.gov" audience="Patient">Supportive care</GlossaryTermRef> is given to lessen the problems caused by the disease or its treatment. Supportive care for pancreatic NETs may include treatment for the following:</Para><ItemizedList id="_206" Style="bullet"><ListItem>Stomach <GlossaryTermRef href="CDR0000269469" dictionary="Cancer.gov" audience="Patient">ulcers</GlossaryTermRef> may be treated with drug <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef> such as:<ItemizedList id="_207" Style="dash"><ListItem><GlossaryTermRef href="CDR0000691415" dictionary="Cancer.gov" audience="Patient">Proton pump inhibitor</GlossaryTermRef> drugs such as <GlossaryTermRef href="CDR0000045450" dictionary="Cancer.gov" audience="Patient">omeprazole</GlossaryTermRef>, <GlossaryTermRef href="CDR0000691418" dictionary="Cancer.gov" audience="Patient">lansoprazole</GlossaryTermRef>, or pantoprazole.</ListItem><ListItem>Histamine blocking drugs such as <GlossaryTermRef href="CDR0000045184" dictionary="Cancer.gov" audience="Patient">cimetidine</GlossaryTermRef>, ranitidine, or famotidine.</ListItem><ListItem>Somatostatin-type drugs such as <GlossaryTermRef href="CDR0000045141" dictionary="Cancer.gov" audience="Patient">octreotide</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem><GlossaryTermRef href="CDR0000306496" dictionary="Cancer.gov" audience="Patient">Diarrhea</GlossaryTermRef> may be treated with: <ItemizedList id="_208" Style="dash"><ListItem><GlossaryTermRef href="CDR0000046682" dictionary="Cancer.gov" audience="Patient">Intravenous</GlossaryTermRef> (IV) <GlossaryTermRef href="CDR0000044669" dictionary="Cancer.gov" audience="Patient">fluids</GlossaryTermRef> with <GlossaryTermRef href="CDR0000044338" dictionary="Cancer.gov" audience="Patient">electrolytes</GlossaryTermRef> such as <GlossaryTermRef href="CDR0000044344" dictionary="Cancer.gov" audience="Patient">potassium</GlossaryTermRef> or chloride. </ListItem><ListItem>Somatostatin-type drugs such as octreotide.</ListItem></ItemizedList></ListItem><ListItem>Low <GlossaryTermRef href="CDR0000658770" dictionary="Cancer.gov" audience="Patient">blood sugar</GlossaryTermRef> may be treated by having small, frequent meals or with <GlossaryTermRef href="CDR0000651195" dictionary="Cancer.gov" audience="Patient">drug therapy</GlossaryTermRef> to maintain a normal blood sugar level.</ListItem><ListItem><GlossaryTermRef href="CDR0000597245" dictionary="Cancer.gov" audience="Patient">High blood sugar</GlossaryTermRef> may be treated with drugs taken by mouth or <GlossaryTermRef href="CDR0000046187" dictionary="Cancer.gov" audience="Patient">insulin</GlossaryTermRef> by <GlossaryTermRef href="CDR0000044678" dictionary="Cancer.gov" audience="Patient">injection</GlossaryTermRef>.</ListItem></ItemizedList></SummarySection></SummarySection><SummarySection id="_117"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_118">New types of treatment are being tested in clinical 
         trials.</KeyPoint><Para id="_119">Information about clinical trials is available from the 
         <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI website</ExternalRef>.</Para></SummarySection><SummarySection id="_250"><KeyPoint id="_251">Treatment for pancreatic neuroendocrine tumors may cause side effects.</KeyPoint><Para id="_250_md_73">For information about <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> caused by treatment for cancer, visit our <ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/side-effects">Side Effects</ExternalRef> page.</Para></SummarySection><SummarySection id="_120"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_121">Patients may want to think about taking part in a 
         clinical trial.</KeyPoint><Para id="_120_md_23">For some patients, taking part in a <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trial</GlossaryTermRef> may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer  treatments are safe and effective or better than the <GlossaryTermRef href="CDR0000044930" dictionary="Cancer.gov" audience="Patient">standard treatment</GlossaryTermRef>.</Para><Para id="_120_md_24">Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first  to receive a new treatment.</Para><Para id="_120_md_25">Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.</Para></SummarySection><SummarySection id="_122"><SectMetaData><SectionType>Treatment in clinical trials</SectionType></SectMetaData><KeyPoint id="_123">Patients can enter clinical trials before, during, or 
         after starting their cancer treatment.</KeyPoint><Para id="_122_md_29">Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the <GlossaryTermRef href="CDR0000046580" dictionary="Cancer.gov" audience="Patient">side effects</GlossaryTermRef> of cancer treatment.</Para><Para id="_122_md_30">Clinical trials are taking place in many parts of the country. Information about clinical trials supported by NCI can be found on NCI’s <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trials search</ExternalRef> webpage. Clinical trials supported by other organizations can be found on the <ExternalRef xref="https://clinicaltrials.gov/">ClinicalTrials.gov</ExternalRef> website.</Para></SummarySection><SummarySection id="_124"><SectMetaData><SectionType>Post-treatment considerations</SectionType></SectMetaData><KeyPoint id="_125">Follow-up tests may be needed.</KeyPoint><Para id="_124_md_33">As you go through treatment, you  will have follow-up tests or check-ups. Some tests that were done to <GlossaryTermRef href="CDR0000046450" dictionary="Cancer.gov" audience="Patient">diagnose</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045885" dictionary="Cancer.gov" audience="Patient">stage</GlossaryTermRef> the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.</Para><Para id="_124_md_34">Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). </Para></SummarySection></SummarySection><SummarySection id="_66"><SectMetaData><SpecificDiagnosis ref="CDR0000038718">gastrinoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Gastrinoma</Title><Para id="_252">For information about the treatments listed below, see the <SummaryRef href="CDR0000062678#_47" url="/types/pancreatic/patient/pnet-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_68"> 
Treatment of <GlossaryTermRef href="CDR0000044239" dictionary="Cancer.gov" audience="Patient">gastrinoma</GlossaryTermRef> may include <SummaryRef href="CDR0000062678#_203" url="/types/pancreatic/patient/pnet-treatment-pdq">supportive care</SummaryRef> and the following:</Para><ItemizedList id="_153" Style="bullet"><ListItem>For <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> caused by too much <GlossaryTermRef href="CDR0000657842" dictionary="Cancer.gov" audience="Patient">stomach acid</GlossaryTermRef>, treatment may be a <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drug</GlossaryTermRef> that decreases the amount of acid made by the stomach.</ListItem><ListItem>For a single <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> in the head of the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef>:<ItemizedList id="_154" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> to remove the tumor.</ListItem><ListItem>Surgery to cut the <GlossaryTermRef href="CDR0000373935" dictionary="Cancer.gov" audience="Patient">nerve</GlossaryTermRef> that causes stomach <GlossaryTermRef href="CDR0000046476" dictionary="Cancer.gov" audience="Patient">cells</GlossaryTermRef> to make acid and treatment with a drug that decreases stomach acid.</ListItem><ListItem>Surgery to remove the whole stomach (rare).</ListItem></ItemizedList></ListItem><ListItem>For a single tumor in the body or tail of the pancreas, treatment is usually surgery to remove the body or  tail of the
				pancreas. </ListItem><ListItem>For several tumors in the pancreas, treatment is usually surgery to remove the body or  tail of the
				pancreas. If tumor remains after surgery, treatment may include either:<ItemizedList id="_155" Style="dash"><ListItem>Surgery to cut the nerve that causes stomach cells to make acid and treatment with a drug that decreases stomach acid; or</ListItem><ListItem>Surgery to remove the whole stomach (rare).</ListItem></ItemizedList></ListItem><ListItem>For one or more tumors in the <GlossaryTermRef href="CDR0000046443" dictionary="Cancer.gov" audience="Patient">duodenum</GlossaryTermRef> (the part of the <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef> that connects to the stomach), treatment is usually <GlossaryTermRef href="CDR0000717157" dictionary="Cancer.gov" audience="Patient">pancreatoduodenectomy</GlossaryTermRef> (surgery to remove the head of the pancreas, the <GlossaryTermRef href="CDR0000046395" dictionary="Cancer.gov" audience="Patient">gallbladder</GlossaryTermRef>, nearby <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> and part of the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046738" dictionary="Cancer.gov" audience="Patient">bile duct</GlossaryTermRef>).</ListItem><ListItem>If no tumor is found, treatment may include the following:<ItemizedList id="_156" Style="dash"><ListItem>Surgery to cut the nerve that causes stomach cells to make acid and treatment with a drug that decreases stomach acid.</ListItem><ListItem>Surgery to remove the whole stomach (rare).</ListItem></ItemizedList></ListItem><ListItem>If the <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> has spread to the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef>, treatment may include:<ItemizedList id="_157" Style="dash"><ListItem>Surgery to remove part or all of the liver.</ListItem><ListItem><GlossaryTermRef href="CDR0000044865" dictionary="Cancer.gov" audience="Patient">Radiofrequency ablation</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">cryosurgical</GlossaryTermRef> <GlossaryTermRef href="CDR0000335061" dictionary="Cancer.gov" audience="Patient">ablation</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046708" dictionary="Cancer.gov" audience="Patient">Chemoembolization</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem>If cancer has spread to other parts of the body or does not get better with surgery or drugs to decrease stomach acid, treatment may include:<ItemizedList id="_158" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">Hormone therapy</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem>If the cancer mostly affects the liver and the patient has severe symptoms from <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> or from the size of tumor, treatment may include:<ItemizedList id="_194" Style="dash"><ListItem><GlossaryTermRef href="CDR0000458102" dictionary="Cancer.gov" audience="Patient">Hepatic arterial occlusion</GlossaryTermRef>, with or without <GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem>Chemoembolization, with or without systemic chemotherapy.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_TrialSearch_66_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_259"><SectMetaData><SpecificDiagnosis ref="CDR0000038792">insulinoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Insulinoma</Title><Para id="_260">For information about the treatments listed below, see the <SummaryRef href="CDR0000062678#_47" url="/types/pancreatic/patient/pnet-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_261">Treatment of <GlossaryTermRef href="CDR0000657853" dictionary="Cancer.gov" audience="Patient">insulinoma</GlossaryTermRef> may include the following:</Para><ItemizedList id="_262" Style="bullet"><ListItem>For one small <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> in the head or tail of the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef>, treatment is usually <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgery</GlossaryTermRef> to remove the tumor.</ListItem><ListItem>For one large tumor in the head of the pancreas that cannot be removed by surgery, treatment is usually <GlossaryTermRef href="CDR0000717157" dictionary="Cancer.gov" audience="Patient">pancreatoduodenectomy</GlossaryTermRef> (surgery to remove the head of the pancreas, the <GlossaryTermRef href="CDR0000046395" dictionary="Cancer.gov" audience="Patient">gallbladder</GlossaryTermRef>, nearby <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> and part of the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046738" dictionary="Cancer.gov" audience="Patient">bile duct</GlossaryTermRef>). </ListItem><ListItem>For one large tumor  in  the body or tail of the pancreas, treatment is usually a <GlossaryTermRef href="CDR0000044519" dictionary="Cancer.gov" audience="Patient">distal pancreatectomy</GlossaryTermRef> (surgery to remove the body and  tail of the
				pancreas).</ListItem><ListItem>For more than one tumor in the pancreas, treatment is usually surgery to remove any tumors in the head of the pancreas and the body and  tail of the
				pancreas.</ListItem><ListItem>For tumors that cannot be removed by surgery, treatment may include the following:<ItemizedList id="_263" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045650" dictionary="Cancer.gov" audience="Patient">Combination chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045815" dictionary="Cancer.gov" audience="Patient">Palliative</GlossaryTermRef> <GlossaryTermRef href="CDR0000348921" dictionary="Cancer.gov" audience="Patient">drug</GlossaryTermRef> <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef> to decrease the amount  of <GlossaryTermRef href="CDR0000046187" dictionary="Cancer.gov" audience="Patient">insulin</GlossaryTermRef> made by the pancreas.</ListItem><ListItem><GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">Hormone therapy</GlossaryTermRef>.</ListItem><ListItem>Radiofrequency ablation or  cryosurgical ablation.</ListItem>
     
     
</ItemizedList></ListItem><ListItem>For cancer that has spread to <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> or other parts of the body, treatment may include the following:<ItemizedList id="_264" Style="dash"><ListItem>Surgery to remove the cancer.  </ListItem><ListItem><GlossaryTermRef href="CDR0000044865" dictionary="Cancer.gov" audience="Patient">Radiofrequency ablation</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">cryosurgical</GlossaryTermRef> <GlossaryTermRef href="CDR0000335061" dictionary="Cancer.gov" audience="Patient">ablation</GlossaryTermRef>, if the cancer cannot be removed by surgery.</ListItem></ItemizedList></ListItem><ListItem>If the <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef>  mostly affects the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef> and the patient has  severe <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> from <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> or from the size of tumor, treatment may include:<ItemizedList id="_265" Style="dash"><ListItem><GlossaryTermRef href="CDR0000458102" dictionary="Cancer.gov" audience="Patient">Hepatic arterial occlusion</GlossaryTermRef>, with or without <GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046708" dictionary="Cancer.gov" audience="Patient">Chemoembolization</GlossaryTermRef>, with or without systemic chemotherapy.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_TrialSearch_259_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_150"><SectMetaData><SpecificDiagnosis ref="CDR0000038989">glucagonoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Glucagonoma</Title><Para id="_266">For information about the treatments listed below, see the <SummaryRef href="CDR0000062678#_47" url="/types/pancreatic/patient/pnet-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_151">
Treatment may include the following:

 
</Para><ItemizedList id="_168" Style="bullet"><ListItem>For one small <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> in the head or tail of the <GlossaryTermRef href="CDR0000046254" dictionary="Cancer.gov" audience="Patient">pancreas</GlossaryTermRef>, treatment is usually <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">surgery</GlossaryTermRef> to remove the tumor.</ListItem><ListItem>For one large tumor in the head of the pancreas that cannot be removed by surgery, treatment is usually <GlossaryTermRef href="CDR0000717157" dictionary="Cancer.gov" audience="Patient">pancreatoduodenectomy</GlossaryTermRef> (surgery to remove the head of the pancreas, the <GlossaryTermRef href="CDR0000046395" dictionary="Cancer.gov" audience="Patient">gallbladder</GlossaryTermRef>, nearby <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef> and part of the <GlossaryTermRef href="CDR0000046604" dictionary="Cancer.gov" audience="Patient">stomach</GlossaryTermRef>, <GlossaryTermRef href="CDR0000046582" dictionary="Cancer.gov" audience="Patient">small intestine</GlossaryTermRef>, and <GlossaryTermRef href="CDR0000046738" dictionary="Cancer.gov" audience="Patient">bile duct</GlossaryTermRef>).</ListItem><ListItem>For more than one tumor in the pancreas, treatment is usually surgery to remove the tumor or surgery to remove the body and tail of the pancreas.</ListItem><ListItem>For tumors that cannot be removed by surgery, treatment may include the following:<ItemizedList id="_174" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045650" dictionary="Cancer.gov" audience="Patient">Combination chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">Hormone therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000044865" dictionary="Cancer.gov" audience="Patient">Radiofrequency ablation</GlossaryTermRef> or  <GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">cryosurgical</GlossaryTermRef> ablation.</ListItem></ItemizedList></ListItem><ListItem>For cancer that has spread to lymph nodes or other parts of the body, treatment may include the following:<ItemizedList id="_169" Style="dash"><ListItem>Surgery to remove the cancer.  </ListItem><ListItem>Radiofrequency ablation or cryosurgical <GlossaryTermRef href="CDR0000335061" dictionary="Cancer.gov" audience="Patient">ablation</GlossaryTermRef>, if the cancer cannot be removed by surgery.</ListItem></ItemizedList></ListItem><ListItem>If the <GlossaryTermRef href="CDR0000045333" dictionary="Cancer.gov" audience="Patient">cancer</GlossaryTermRef> mostly affects the <GlossaryTermRef href="CDR0000046312" dictionary="Cancer.gov" audience="Patient">liver</GlossaryTermRef> and the patient has  severe <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> from <GlossaryTermRef href="CDR0000045713" dictionary="Cancer.gov" audience="Patient">hormones</GlossaryTermRef> or from the size of tumor, treatment may include:<ItemizedList id="_227" Style="dash"><ListItem><GlossaryTermRef href="CDR0000458102" dictionary="Cancer.gov" audience="Patient">Hepatic arterial occlusion</GlossaryTermRef>, with or without <GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000046708" dictionary="Cancer.gov" audience="Patient">Chemoembolization</GlossaryTermRef>, with or without systemic chemotherapy.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_TrialSearch_150_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_74"><SectMetaData><SpecificDiagnosis ref="CDR0000550688">pancreatic neuroendocrine tumor</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Other Pancreatic Neuroendocrine Tumors (Islet Cell Tumors)</Title><Para id="_267">For information about the treatments listed below, see the <SummaryRef href="CDR0000062678#_47" url="/types/pancreatic/patient/pnet-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_228">For VIPoma, treatment may include the following:</Para><ItemizedList id="_229" Style="bullet"><ListItem><GlossaryTermRef href="CDR0000044669" dictionary="Cancer.gov" audience="Patient">Fluids</GlossaryTermRef> and <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef> to  replace fluids and  <GlossaryTermRef href="CDR0000044338" dictionary="Cancer.gov" audience="Patient">electrolytes</GlossaryTermRef> that have been lost from the body.</ListItem><ListItem><GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> to remove the <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef> and nearby <GlossaryTermRef href="CDR0000045762" dictionary="Cancer.gov" audience="Patient">lymph nodes</GlossaryTermRef>.</ListItem><ListItem>Surgery to remove as much of the tumor as possible when the tumor cannot be completely removed or has spread to distant parts of the body. This is <GlossaryTermRef href="CDR0000045815" dictionary="Cancer.gov" audience="Patient">palliative therapy</GlossaryTermRef> to relieve <GlossaryTermRef href="CDR0000045022" dictionary="Cancer.gov" audience="Patient">symptoms</GlossaryTermRef> and improve the <GlossaryTermRef href="CDR0000045417" dictionary="Cancer.gov" audience="Patient">quality of life</GlossaryTermRef>. </ListItem><ListItem>For tumors that have spread to lymph nodes or other parts of the body, treatment may include the following:<ItemizedList id="_230" Style="dash"><ListItem>Surgery to remove the tumor.  </ListItem><ListItem><GlossaryTermRef href="CDR0000044865" dictionary="Cancer.gov" audience="Patient">Radiofrequency ablation</GlossaryTermRef> or <GlossaryTermRef href="CDR0000045407" dictionary="Cancer.gov" audience="Patient">cryosurgical</GlossaryTermRef> <GlossaryTermRef href="CDR0000335061" dictionary="Cancer.gov" audience="Patient">ablation</GlossaryTermRef>, if the tumor cannot be removed by surgery.</ListItem></ItemizedList></ListItem><ListItem>For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:<ItemizedList id="_231" Style="dash"><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef>.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_222"> For somatostatinoma, treatment may include the following:</Para><ItemizedList id="_232" Style="bullet"><ListItem>Surgery to remove the tumor.</ListItem><ListItem>For cancer that has spread to distant parts of the body, surgery to remove as much of the cancer as possible to relieve symptoms and improve quality of life.</ListItem><ListItem>For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:<ItemizedList id="_233" Style="dash"><ListItem>Chemotherapy.</ListItem><ListItem>Targeted therapy.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_90"> 
Treatment of other types of <GlossaryTermRef href="CDR0000753531" dictionary="Cancer.gov" audience="Patient">pancreatic neuroendocrine tumors</GlossaryTermRef> (NETs) may include the following:</Para><ItemizedList id="_234" Style="bullet"><ListItem>Surgery to remove the tumor.</ListItem><ListItem>For cancer that has spread to distant parts of the body, surgery to remove as much of the cancer as possible or hormone therapy to relieve symptoms and improve quality of life.</ListItem><ListItem>For tumors that continue to grow during treatment or have spread to other parts of the body, treatment may include the following:<ItemizedList id="_235" Style="dash"><ListItem>Chemotherapy.</ListItem><ListItem>Targeted therapy.</ListItem></ItemizedList></ListItem></ItemizedList><Para id="_TrialSearch_74_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_78"><SectMetaData><SpecificDiagnosis ref="CDR0000038794">recurrent islet cell carcinoma</SpecificDiagnosis><SectionType>Treatment options by stage</SectionType></SectMetaData><Title>Treatment of Recurrent or Progressive Pancreatic Neuroendocrine Tumors
(Islet Cell Tumors)</Title><Para id="_268">For information about the treatments listed below, see the <SummaryRef href="CDR0000062678#_47" url="/types/pancreatic/patient/pnet-treatment-pdq">Treatment Option Overview</SummaryRef> section.</Para><Para id="_92">Treatment of <GlossaryTermRef href="CDR0000753531" dictionary="Cancer.gov" audience="Patient">pancreatic neuroendocrine tumors</GlossaryTermRef> (NETs) that continue to grow during treatment or <GlossaryTermRef href="CDR0000046556" dictionary="Cancer.gov" audience="Patient">recur</GlossaryTermRef> (come back) may include the following:</Para><ItemizedList id="_80" Style="bullet">
     
	  
	  
	  <ListItem>

    <GlossaryTermRef href="CDR0000045570" dictionary="Cancer.gov" audience="Patient">Surgery</GlossaryTermRef> to remove the <GlossaryTermRef href="CDR0000046634" dictionary="Cancer.gov" audience="Patient">tumor</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">Chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">Hormone therapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000270742" dictionary="Cancer.gov" audience="Patient">Targeted therapy</GlossaryTermRef>.</ListItem><ListItem>For <GlossaryTermRef href="CDR0000045316" dictionary="Cancer.gov" audience="Patient">liver metastases</GlossaryTermRef>:<ItemizedList id="_236" Style="dash">
     <ListItem><GlossaryTermRef href="CDR0000046559" dictionary="Cancer.gov" audience="Patient">Regional chemotherapy</GlossaryTermRef>.</ListItem><ListItem><GlossaryTermRef href="CDR0000458102" dictionary="Cancer.gov" audience="Patient">Hepatic arterial occlusion</GlossaryTermRef> or <GlossaryTermRef href="CDR0000046708" dictionary="Cancer.gov" audience="Patient">chemoembolization</GlossaryTermRef>, with or without <GlossaryTermRef href="CDR0000301626" dictionary="Cancer.gov" audience="Patient">systemic chemotherapy</GlossaryTermRef>.</ListItem></ItemizedList></ListItem><ListItem>A <GlossaryTermRef href="CDR0000045961" dictionary="Cancer.gov" audience="Patient">clinical trial</GlossaryTermRef> of a new <GlossaryTermRef href="CDR0000044737" dictionary="Cancer.gov" audience="Patient">therapy</GlossaryTermRef>.</ListItem>
	  
	  </ItemizedList><SummarySection id="_126"><SectMetaData><SectionType>Resources</SectionType></SectMetaData><Title>To Learn More About Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) </Title><Para id="_127">For more information from the <GlossaryTermRef href="CDR0000044266" dictionary="Cancer.gov" audience="Patient">National Cancer Institute</GlossaryTermRef> about  pancreatic neuroendocrine tumors (NETs), see the following:</Para><ItemizedList id="_240" Style="bullet"><ListItem><ExternalRef xref="https://www.cancer.gov/types/pancreatic">Pancreatic Cancer Home Page</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Cancer Therapies</ExternalRef></ListItem></ItemizedList><Para id="_126_md_40">For general cancer information and other resources from the National Cancer Institute, visit:</Para><ItemizedList id="_126_md_41" Style="bullet"><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer">About Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/diagnosis-staging/staging">Cancer Staging</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/publications/patient-education/chemo-and-you">Chemotherapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/publications/patient-education/radiation-therapy-and-you">Radiation Therapy and You: Support for People With Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping">Coping with Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://www.cancer.gov/about-cancer/coping/questions">Questions to Ask Your Doctor about Cancer</ExternalRef></ListItem><ListItem><ExternalRef xref="https://cancercontrol.cancer.gov/ocs/resources/survivors.html">For Survivors, Caregivers, and Advocates</ExternalRef></ListItem></ItemizedList></SummarySection><Para id="_TrialSearch_78_19">Use our <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials-search">clinical trial search</ExternalRef> to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">General information</ExternalRef>  about clinical trials is also available.</Para></SummarySection><SummarySection id="_AboutThis_1"><Title>About This PDQ Summary</Title><SummarySection id="_AboutThis_2"><Title>About PDQ</Title><Para id="_AboutThis_3">Physician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in <ExternalRef xref="https://www.cancer.gov/espanol/publicaciones/pdq">Spanish</ExternalRef>.</Para><Para id="_AboutThis_4">PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government’s center of biomedical research.  The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.</Para></SummarySection><SummarySection id="_AboutThis_5"><Title>Purpose of This Summary</Title><Para id="_AboutThis_6">This PDQ cancer information summary has current information about the treatment of pancreatic neuroendocrine tumors (islet cell tumors).  It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care.</Para></SummarySection><SummarySection id="_AboutThis_7"><Title>Reviewers and Updates</Title><Para id="_AboutThis_8">Editorial Boards write the PDQ cancer information summaries and keep them up to date. These Boards are made up of experts in cancer treatment and other specialties related to cancer. The summaries are reviewed regularly and changes are made when there is new information. The date on each summary ("Updated") is the date of the most recent change.
</Para><Para id="_AboutThis_9">The information in this patient summary was taken from the health professional version, which is reviewed regularly and updated as needed, by the <ExternalRef xref="https://www.cancer.gov/publications/pdq/editorial-boards/adult-treatment">PDQ Adult Treatment Editorial Board</ExternalRef>.
</Para></SummarySection><SummarySection id="_AboutThis_10"><Title>Clinical Trial Information</Title><Para id="_AboutThis_11">A clinical trial is a study to answer a scientific question, such as whether one treatment is better than another. Trials are based on past studies and what has been learned in the laboratory. Each trial answers certain scientific questions in order to find new and better ways to help cancer patients. During treatment clinical trials, information is collected about the effects of a new treatment and how well it works. If a clinical trial shows that a new treatment is better than one currently being used, the new treatment may become "standard." Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
</Para><Para id="_AboutThis_12">Clinical trials can be found online at <ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials">NCI's website</ExternalRef>. For more information, call the <ExternalRef xref="https://www.cancer.gov/contact/contact-center">Cancer Information Service</ExternalRef> (CIS), NCI's contact center, at 1-800-4-CANCER (1-800-422-6237).
</Para></SummarySection><SummarySection id="_AboutThis_13"><Title>Permission to Use This Summary</Title><Para id="_AboutThis_14">PDQ is a registered trademark. The content of PDQ documents can be used freely as text. It cannot be identified as an NCI PDQ cancer information summary unless the whole summary is shown and it is updated regularly. However, a user would be allowed to write a sentence such as “NCI’s PDQ cancer information summary about breast cancer prevention states the risks in the following way: [include excerpt from the summary].”
</Para><Para id="_AboutThis_15">The best way to cite this PDQ summary is:</Para><Para id="_AboutThis_21">PDQ® Adult Treatment Editorial Board. PDQ Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment. Bethesda, MD: National Cancer Institute. Updated  &lt;MM/DD/YYYY&gt;. Available at: <ExternalRef xref="https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq">https://www.cancer.gov/types/pancreatic/patient/pnet-treatment-pdq</ExternalRef>.  Accessed &lt;MM/DD/YYYY&gt;. [PMID: 26389340]</Para><Para id="_AboutThis_16">Images in this summary are used with permission of the author(s), artist, and/or publisher for use in the PDQ summaries only. If you want to use an image from a PDQ summary and you are not using the whole summary, you must get permission from the owner. It cannot be given by the National Cancer Institute. Information about using the images in this summary, along with many other images related to cancer can be found in <ExternalRef xref="https://visualsonline.cancer.gov/">Visuals Online</ExternalRef>. Visuals Online is a collection of more than 3,000 scientific images.
</Para></SummarySection><SummarySection id="_AboutThis_17"><Title>Disclaimer</Title><Para id="_AboutThis_18">The information in these summaries should not be used to make decisions about insurance reimbursement. More information on insurance coverage is available on Cancer.gov on the <ExternalRef xref="https://www.cancer.gov/about-cancer/managing-care">Managing Cancer Care</ExternalRef> page.</Para></SummarySection><SummarySection id="_AboutThis_19"><Title>Contact Us</Title><Para id="_AboutThis_20">More information about contacting us or receiving help with the Cancer.gov website can be found on our <ExternalRef xref="https://www.cancer.gov/contact">Contact Us for Help</ExternalRef> page. Questions can also be submitted to Cancer.gov through the website’s <ExternalRef xref="https://www.cancer.gov/contact/email-us">E-mail Us</ExternalRef>.</Para></SummarySection></SummarySection><PatientVersionOf ref="CDR0000062794"/><DateLastModified>2022-10-07</DateLastModified></Summary>
